TY  - JOUR
AU  - Alcaraz, Antonio
AU  - Rodríguez-Antolín, Alfredo
AU  - Carballido-Rodríguez, Joaquín
AU  - Castro-Díaz, David
AU  - Esteban-Fuertes, Manuel
AU  - Cózar-Olmo, José M
AU  - Ficarra, Vincenzo
AU  - Medina-López, Rafael
AU  - Fernández-Gómez, Jesús M
AU  - Angulo, Javier C
AU  - Medina-Polo, José
AU  - Brenes-Bermúdez, Francisco J
AU  - Molero-García, José M
AU  - Fernández-Pro-Ledesma, Antonio
AU  - Manasanch, José
AU  - The Qualiprost Study Group, On Behalf Of
PY  - 2020
DO  - 10.3390/jcm9092909
SN  - 2077-0383
UR  - https://hdl.handle.net/10668/26501
T2  - Journal of clinical medicine
AB  - To investigate whether tamsulosin (TAM) and the hexanic extract of Serenoa repens (HESr) are more effective in combination than as monotherapy in men with moderate-to-severe lower urinary tract symptoms associated with benign prostatic hyperplasia...
LA  - en
KW  - BII
KW  - BPH
KW  - combination treatment
KW  - hexanic extract of Serenoa repens
KW  - moderate-severe LUTS
KW  - quality of life
KW  - storage symptoms
KW  - tamsulosin
KW  - tolerability
TI  - Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study.
TY  - research article
VL  - 9
ER  -